Actively Recruiting
Study of Chemotherapy and Radiation Therapy Followed by Liver Transplant for Unresectable Perihilar Cholangiocarcinoma in Adults Aged 18 to 70
Led by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Updated on 2025-05-23
8
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the effectiveness of liver transplantation after successful disease control in patients with unresectable perihilar cholangiocarcinoma pCCA. This observational study focuses on patients who have undergone chemotherapy with or without immunotherapy and stereotactic body radiation therapy SBRT to downstage their cancer. The study aims to better understand outcomes following this treatment approach, including survival and quality of life over three years. Participants with unresectable pCCA who meet the criteria will first have staging laparoscopy with lymph node sampling. If no spread of disease is found, they will receive two cycles of gemcitabine-cisplatin chemotherapy with or without durvalumab, followed by SBRT, then at least four more cycles of chemotherapy with or without immunotherapy. Disease status will be reassessed, and if stable, patients will undergo transplant screening and be listed for liver transplantation. During listing, restaging with imaging and molecular tests will occur every two months, aiming for transplant within 90 days. Throughout the study, participants will be monitored with CT, MRI, molecular markers, and PET scans to assess disease stability and safety. Researchers will measure overall survival, recurrence-free survival, safety, feasibility, and quality of life over three years. Treatment with chemotherapy and immunotherapy will continue until transplant, disease progression, or unacceptable side effects. The study will follow participants until January 2030.
CONDITIONS
Brief Title
Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
Research Team
V
Vincenzo Mazzaferro, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here